MX9302578A - ANTIVIRAL AGENTS. - Google Patents

ANTIVIRAL AGENTS.

Info

Publication number
MX9302578A
MX9302578A MX9302578A MX9302578A MX9302578A MX 9302578 A MX9302578 A MX 9302578A MX 9302578 A MX9302578 A MX 9302578A MX 9302578 A MX9302578 A MX 9302578A MX 9302578 A MX9302578 A MX 9302578A
Authority
MX
Mexico
Prior art keywords
antiviral agents
heteropolytungstates
prophylaxis
therapy
confirmed
Prior art date
Application number
MX9302578A
Other languages
Spanish (es)
Inventor
Helmut Weigold
Angeline Ingrid Bartholomeusz
George Holan
Sebastian Mario Marcuccio
Peter James Wright
Original Assignee
Commw Scient Ind Res Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commw Scient Ind Res Org filed Critical Commw Scient Ind Res Org
Publication of MX9302578A publication Critical patent/MX9302578A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composiciones farmacéuticas que contienen heteropolitungstatos y derivados farmacéuticamente aceptables de los mismos. El uso de tales compuestos o composiciones en la terapia para el tratamiento o profilaxis de infecciones por virus, los cuales son miembros confirmados o probables de la familia de Flaviviridae.Pharmaceutical compositions containing heteropolytungstates and pharmaceutically acceptable derivatives thereof. The use of such compounds or compositions in therapy for the treatment or prophylaxis of virus infections, which are confirmed or probable members of the Flaviviridae family.

MX9302578A 1992-05-01 1993-04-30 ANTIVIRAL AGENTS. MX9302578A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPL221392 1992-05-01

Publications (1)

Publication Number Publication Date
MX9302578A true MX9302578A (en) 1994-08-31

Family

ID=3776137

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9302578A MX9302578A (en) 1992-05-01 1993-04-30 ANTIVIRAL AGENTS.

Country Status (6)

Country Link
JP (1) JPH07506352A (en)
CN (1) CN1082892A (en)
CA (1) CA2134877A1 (en)
HU (1) HUT71677A (en)
MX (1) MX9302578A (en)
WO (1) WO1993021934A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824706A (en) * 1994-09-26 1998-10-20 Schinazi; Raymond F. Method, compositions, and apparatus for treating and preventing respiratory viral infections
AUPO820197A0 (en) * 1997-07-24 1997-08-14 Biomolecular Research Institute Limited Inorganic angiogenesis inhibitors
AUPO995297A0 (en) * 1997-10-24 1997-11-13 Starpharma Limited Inorganic antiviral compounds
EP1128832A4 (en) * 1998-08-21 2003-03-05 Viropharma Inc Compounds, compositions and methods for treating or preventing viral infections and associated diseases
DE102006023394A1 (en) * 2006-05-17 2007-11-22 Gerd Prof. Wengler Preparation and use of an antiviral chemotherapeutic agent which affects a host cell to block the replication of viruses in the cell
CN107226462A (en) * 2016-03-24 2017-10-03 李泽琳 Polyacid compound, its preparation method and medical usage

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2117803B1 (en) * 1970-12-18 1974-03-22 Anvar
WO1990006756A1 (en) * 1988-12-16 1990-06-28 Terumo Kabushiki Kaisha Antiviral agent
GB8906189D0 (en) * 1989-03-17 1989-05-04 Johnson Matthey Plc Improvements in chemical compounds
GB9003430D0 (en) * 1990-02-15 1990-04-11 Johnson Matthey Plc Improvements in chemical compounds
GB9025847D0 (en) * 1990-11-28 1991-01-09 Johnson Matthey Plc Improvements in chemical compounds

Also Published As

Publication number Publication date
CN1082892A (en) 1994-03-02
JPH07506352A (en) 1995-07-13
WO1993021934A1 (en) 1993-11-11
HU9403128D0 (en) 1995-02-28
CA2134877A1 (en) 1993-11-11
HUT71677A (en) 1996-01-29

Similar Documents

Publication Publication Date Title
ES2149276T3 (en) IMIDAZO (4,5-C) PIRIDIN-4-AMINAS.
ES2186667T3 (en) NUCLEOSIDE ANALOGS OF 1,3-OXATIOLANE.
DK0574457T3 (en) Antiviral nucleoside combination
TR199903053T2 (en) Benzimidazole trevleri.
BR0015605A (en) Composition and use
AR015940A1 (en) RAPAMYCIN DERIVATIVES CONTAINING TETRAZOL WITH SHORT MEDIUM LIVES AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
MX9606732A (en) Therapeutic compounds.
MX9301929A (en) DERIVATIVES OF PIRIMIDINE AND PROCEDURES FOR ITS PREPARATION.
MX9200361A (en) NEW USE OF THE ADENOSINE ANTAGONIST.
MX9204454A (en) THIOUREA DERIVATIVES TO INHIBIT THE REPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS AND THE PHARMACEUTICAL FORMULATE CONTAINING THEM.
ES2150496T3 (en) CONDENSED CYCLLOALKYLIMIDAZOPYRIDIDS.
ATE184598T1 (en) ENNIATINES AND ENNIATINE DERIVATIVES TO FIGHT ENDOPARASITES
AR003455A1 (en) TETRACICLIC DERIVATIVES, THEIR USE IN THE PREPARATION OF A MEDICINAL PRODUCT, A TREATMENT METHOD, A PHARMACEUTICAL COMPOSITION AND PROCESSES FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION AND TO PREPARE THE COMPOUNDS.
ES2083668T5 (en) ANTIVIRICAL COMBINATIONS CONTAINING NUCLEOSIDE ANALOGS.
MX9203972A (en) PROTEASE INHIBITOR COMPOUNDS CODED BY HUMAN IMMUNODEFICIENCY VIRUSES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM.
PA8485601A1 (en) AZALIDAS OF 13 MEMBERS AND THEIR USE AS ANTIBIOTIC AGENTS.
MX9308005A (en) HUMAN IMMUNODEFICIENCY VIRUS PROTEASE INHIBITING COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM.
MX9302578A (en) ANTIVIRAL AGENTS.
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
AP9801286A0 (en) Therapeutic compounds.
DE68900760D1 (en) VIRUS INHIBITING NUCLEOSIDE MIXTURE.
NO983177L (en) Use of the 1-enantiomer of centroman for the preparation of a pharmaceutical composition for the treatment or prophylaxis of breast cancer
AP9801287A0 (en) 2-amino-5, 6-dichlorobenzimidazole derivatives having antiviral activity.
AR021463A1 (en) ANTIBIOTICO DE PIRIDONA WITH IMPROVED SECURITY PROFILE
ES2175661T3 (en) DERIVATIVES OF ISOFLAVONA, PROCEDURES FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.